Review



pe conjugated cd16  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Bio-Rad pe conjugated cd16
    Flow cytometry analysis of MCs collected before and after acute inflammation: (a) MCs’ analysis using CD14 and <t>CD16</t> markers revealed the shift in surface marker intensity of a specific cell population at different stages of acute inflammation. (b) Cell-specific gating showed that primarily monocytes transited toward a CD14++/16+ state following acute inflammation. Interestingly, these cells marker intensity come to initial state after prolonged periods of acute inflammation. (c) The fraction of CD14++/16+ monocytes shows a profile similar to that of in vitro differentiated EC-like cells at different periods of acute inflammation. This implies that monocytes in CD14++/16+ state significantly contribute to the differentiation of EC-like cells in vitro . However, no significant intensity shift was observed in granulocytes or lymphocytes. In vitro treatment of PBMC with IL-6 also promotes monocyte transition toward a CD14++/16+ state and increases the EC-like cell fraction. (d) In vitro IL-6 treatment significantly enhances the population of CD34+, VEGFR2+, and CD163+ monocytes. Data were expressed as means ± standard deviations of one representative experiment out of three experiments carried out in triplicate (one-way ANOVA, Fraction ratio of monocytes: F 3,8 = 9.1, p = 0.0011; granulocytes: F 3,8 = 6.3, p = 0.0030; lymphocytes: F 3,8 = 1.2, p = 0.247, Tukey’s HSD post hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001). Paired t-tests (n = 3) were used to evaluate differences among the groups in (d). Values of p < 0.05 are considered statistically significant, and are presented as follows: # p < 0.05.
    Pe Conjugated Cd16, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 51 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe conjugated cd16/product/Bio-Rad
    Average 93 stars, based on 51 article reviews
    pe conjugated cd16 - by Bioz Stars, 2026-03
    93/100 stars

    Images

    1) Product Images from "Blood mononuclear cells induce accelerated vascular remodeling under acute inflammation in vitro"

    Article Title: Blood mononuclear cells induce accelerated vascular remodeling under acute inflammation in vitro

    Journal: Journal of Tissue Engineering

    doi: 10.1177/20417314251381716

    Flow cytometry analysis of MCs collected before and after acute inflammation: (a) MCs’ analysis using CD14 and CD16 markers revealed the shift in surface marker intensity of a specific cell population at different stages of acute inflammation. (b) Cell-specific gating showed that primarily monocytes transited toward a CD14++/16+ state following acute inflammation. Interestingly, these cells marker intensity come to initial state after prolonged periods of acute inflammation. (c) The fraction of CD14++/16+ monocytes shows a profile similar to that of in vitro differentiated EC-like cells at different periods of acute inflammation. This implies that monocytes in CD14++/16+ state significantly contribute to the differentiation of EC-like cells in vitro . However, no significant intensity shift was observed in granulocytes or lymphocytes. In vitro treatment of PBMC with IL-6 also promotes monocyte transition toward a CD14++/16+ state and increases the EC-like cell fraction. (d) In vitro IL-6 treatment significantly enhances the population of CD34+, VEGFR2+, and CD163+ monocytes. Data were expressed as means ± standard deviations of one representative experiment out of three experiments carried out in triplicate (one-way ANOVA, Fraction ratio of monocytes: F 3,8 = 9.1, p = 0.0011; granulocytes: F 3,8 = 6.3, p = 0.0030; lymphocytes: F 3,8 = 1.2, p = 0.247, Tukey’s HSD post hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001). Paired t-tests (n = 3) were used to evaluate differences among the groups in (d). Values of p < 0.05 are considered statistically significant, and are presented as follows: # p < 0.05.
    Figure Legend Snippet: Flow cytometry analysis of MCs collected before and after acute inflammation: (a) MCs’ analysis using CD14 and CD16 markers revealed the shift in surface marker intensity of a specific cell population at different stages of acute inflammation. (b) Cell-specific gating showed that primarily monocytes transited toward a CD14++/16+ state following acute inflammation. Interestingly, these cells marker intensity come to initial state after prolonged periods of acute inflammation. (c) The fraction of CD14++/16+ monocytes shows a profile similar to that of in vitro differentiated EC-like cells at different periods of acute inflammation. This implies that monocytes in CD14++/16+ state significantly contribute to the differentiation of EC-like cells in vitro . However, no significant intensity shift was observed in granulocytes or lymphocytes. In vitro treatment of PBMC with IL-6 also promotes monocyte transition toward a CD14++/16+ state and increases the EC-like cell fraction. (d) In vitro IL-6 treatment significantly enhances the population of CD34+, VEGFR2+, and CD163+ monocytes. Data were expressed as means ± standard deviations of one representative experiment out of three experiments carried out in triplicate (one-way ANOVA, Fraction ratio of monocytes: F 3,8 = 9.1, p = 0.0011; granulocytes: F 3,8 = 6.3, p = 0.0030; lymphocytes: F 3,8 = 1.2, p = 0.247, Tukey’s HSD post hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001). Paired t-tests (n = 3) were used to evaluate differences among the groups in (d). Values of p < 0.05 are considered statistically significant, and are presented as follows: # p < 0.05.

    Techniques Used: Flow Cytometry, Marker, In Vitro



    Similar Products

    pe conjugated cd16  (Bio-Rad)
    93
    Bio-Rad pe conjugated cd16
    Flow cytometry analysis of MCs collected before and after acute inflammation: (a) MCs’ analysis using CD14 and <t>CD16</t> markers revealed the shift in surface marker intensity of a specific cell population at different stages of acute inflammation. (b) Cell-specific gating showed that primarily monocytes transited toward a CD14++/16+ state following acute inflammation. Interestingly, these cells marker intensity come to initial state after prolonged periods of acute inflammation. (c) The fraction of CD14++/16+ monocytes shows a profile similar to that of in vitro differentiated EC-like cells at different periods of acute inflammation. This implies that monocytes in CD14++/16+ state significantly contribute to the differentiation of EC-like cells in vitro . However, no significant intensity shift was observed in granulocytes or lymphocytes. In vitro treatment of PBMC with IL-6 also promotes monocyte transition toward a CD14++/16+ state and increases the EC-like cell fraction. (d) In vitro IL-6 treatment significantly enhances the population of CD34+, VEGFR2+, and CD163+ monocytes. Data were expressed as means ± standard deviations of one representative experiment out of three experiments carried out in triplicate (one-way ANOVA, Fraction ratio of monocytes: F 3,8 = 9.1, p = 0.0011; granulocytes: F 3,8 = 6.3, p = 0.0030; lymphocytes: F 3,8 = 1.2, p = 0.247, Tukey’s HSD post hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001). Paired t-tests (n = 3) were used to evaluate differences among the groups in (d). Values of p < 0.05 are considered statistically significant, and are presented as follows: # p < 0.05.
    Pe Conjugated Cd16, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe conjugated cd16/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    pe conjugated cd16 - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    anti cd16  (Bio-Rad)
    93
    Bio-Rad anti cd16
    Flow cytometry analysis of MCs collected before and after acute inflammation: (a) MCs’ analysis using CD14 and <t>CD16</t> markers revealed the shift in surface marker intensity of a specific cell population at different stages of acute inflammation. (b) Cell-specific gating showed that primarily monocytes transited toward a CD14++/16+ state following acute inflammation. Interestingly, these cells marker intensity come to initial state after prolonged periods of acute inflammation. (c) The fraction of CD14++/16+ monocytes shows a profile similar to that of in vitro differentiated EC-like cells at different periods of acute inflammation. This implies that monocytes in CD14++/16+ state significantly contribute to the differentiation of EC-like cells in vitro . However, no significant intensity shift was observed in granulocytes or lymphocytes. In vitro treatment of PBMC with IL-6 also promotes monocyte transition toward a CD14++/16+ state and increases the EC-like cell fraction. (d) In vitro IL-6 treatment significantly enhances the population of CD34+, VEGFR2+, and CD163+ monocytes. Data were expressed as means ± standard deviations of one representative experiment out of three experiments carried out in triplicate (one-way ANOVA, Fraction ratio of monocytes: F 3,8 = 9.1, p = 0.0011; granulocytes: F 3,8 = 6.3, p = 0.0030; lymphocytes: F 3,8 = 1.2, p = 0.247, Tukey’s HSD post hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001). Paired t-tests (n = 3) were used to evaluate differences among the groups in (d). Values of p < 0.05 are considered statistically significant, and are presented as follows: # p < 0.05.
    Anti Cd16, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd16/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    anti cd16 - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    cd16  (Bio-Rad)
    93
    Bio-Rad cd16
    Flow cytometry analysis of MCs collected before and after acute inflammation: (a) MCs’ analysis using CD14 and <t>CD16</t> markers revealed the shift in surface marker intensity of a specific cell population at different stages of acute inflammation. (b) Cell-specific gating showed that primarily monocytes transited toward a CD14++/16+ state following acute inflammation. Interestingly, these cells marker intensity come to initial state after prolonged periods of acute inflammation. (c) The fraction of CD14++/16+ monocytes shows a profile similar to that of in vitro differentiated EC-like cells at different periods of acute inflammation. This implies that monocytes in CD14++/16+ state significantly contribute to the differentiation of EC-like cells in vitro . However, no significant intensity shift was observed in granulocytes or lymphocytes. In vitro treatment of PBMC with IL-6 also promotes monocyte transition toward a CD14++/16+ state and increases the EC-like cell fraction. (d) In vitro IL-6 treatment significantly enhances the population of CD34+, VEGFR2+, and CD163+ monocytes. Data were expressed as means ± standard deviations of one representative experiment out of three experiments carried out in triplicate (one-way ANOVA, Fraction ratio of monocytes: F 3,8 = 9.1, p = 0.0011; granulocytes: F 3,8 = 6.3, p = 0.0030; lymphocytes: F 3,8 = 1.2, p = 0.247, Tukey’s HSD post hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001). Paired t-tests (n = 3) were used to evaluate differences among the groups in (d). Values of p < 0.05 are considered statistically significant, and are presented as follows: # p < 0.05.
    Cd16, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd16/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    cd16 - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    mca1971ga bio rad  (Bio-Rad)
    93
    Bio-Rad mca1971ga bio rad
    Flow cytometry analysis of MCs collected before and after acute inflammation: (a) MCs’ analysis using CD14 and <t>CD16</t> markers revealed the shift in surface marker intensity of a specific cell population at different stages of acute inflammation. (b) Cell-specific gating showed that primarily monocytes transited toward a CD14++/16+ state following acute inflammation. Interestingly, these cells marker intensity come to initial state after prolonged periods of acute inflammation. (c) The fraction of CD14++/16+ monocytes shows a profile similar to that of in vitro differentiated EC-like cells at different periods of acute inflammation. This implies that monocytes in CD14++/16+ state significantly contribute to the differentiation of EC-like cells in vitro . However, no significant intensity shift was observed in granulocytes or lymphocytes. In vitro treatment of PBMC with IL-6 also promotes monocyte transition toward a CD14++/16+ state and increases the EC-like cell fraction. (d) In vitro IL-6 treatment significantly enhances the population of CD34+, VEGFR2+, and CD163+ monocytes. Data were expressed as means ± standard deviations of one representative experiment out of three experiments carried out in triplicate (one-way ANOVA, Fraction ratio of monocytes: F 3,8 = 9.1, p = 0.0011; granulocytes: F 3,8 = 6.3, p = 0.0030; lymphocytes: F 3,8 = 1.2, p = 0.247, Tukey’s HSD post hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001). Paired t-tests (n = 3) were used to evaluate differences among the groups in (d). Values of p < 0.05 are considered statistically significant, and are presented as follows: # p < 0.05.
    Mca1971ga Bio Rad, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mca1971ga bio rad/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    mca1971ga bio rad - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    unlabeled mouse anti pig cd16  (Bio-Rad)
    93
    Bio-Rad unlabeled mouse anti pig cd16
    Flow cytometry analysis of MCs collected before and after acute inflammation: (a) MCs’ analysis using CD14 and <t>CD16</t> markers revealed the shift in surface marker intensity of a specific cell population at different stages of acute inflammation. (b) Cell-specific gating showed that primarily monocytes transited toward a CD14++/16+ state following acute inflammation. Interestingly, these cells marker intensity come to initial state after prolonged periods of acute inflammation. (c) The fraction of CD14++/16+ monocytes shows a profile similar to that of in vitro differentiated EC-like cells at different periods of acute inflammation. This implies that monocytes in CD14++/16+ state significantly contribute to the differentiation of EC-like cells in vitro . However, no significant intensity shift was observed in granulocytes or lymphocytes. In vitro treatment of PBMC with IL-6 also promotes monocyte transition toward a CD14++/16+ state and increases the EC-like cell fraction. (d) In vitro IL-6 treatment significantly enhances the population of CD34+, VEGFR2+, and CD163+ monocytes. Data were expressed as means ± standard deviations of one representative experiment out of three experiments carried out in triplicate (one-way ANOVA, Fraction ratio of monocytes: F 3,8 = 9.1, p = 0.0011; granulocytes: F 3,8 = 6.3, p = 0.0030; lymphocytes: F 3,8 = 1.2, p = 0.247, Tukey’s HSD post hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001). Paired t-tests (n = 3) were used to evaluate differences among the groups in (d). Values of p < 0.05 are considered statistically significant, and are presented as follows: # p < 0.05.
    Unlabeled Mouse Anti Pig Cd16, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/unlabeled mouse anti pig cd16/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    unlabeled mouse anti pig cd16 - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    cd16 g7 pig igg1  (Bio-Rad)
    93
    Bio-Rad cd16 g7 pig igg1
    Flow cytometry analysis of MCs collected before and after acute inflammation: (a) MCs’ analysis using CD14 and <t>CD16</t> markers revealed the shift in surface marker intensity of a specific cell population at different stages of acute inflammation. (b) Cell-specific gating showed that primarily monocytes transited toward a CD14++/16+ state following acute inflammation. Interestingly, these cells marker intensity come to initial state after prolonged periods of acute inflammation. (c) The fraction of CD14++/16+ monocytes shows a profile similar to that of in vitro differentiated EC-like cells at different periods of acute inflammation. This implies that monocytes in CD14++/16+ state significantly contribute to the differentiation of EC-like cells in vitro . However, no significant intensity shift was observed in granulocytes or lymphocytes. In vitro treatment of PBMC with IL-6 also promotes monocyte transition toward a CD14++/16+ state and increases the EC-like cell fraction. (d) In vitro IL-6 treatment significantly enhances the population of CD34+, VEGFR2+, and CD163+ monocytes. Data were expressed as means ± standard deviations of one representative experiment out of three experiments carried out in triplicate (one-way ANOVA, Fraction ratio of monocytes: F 3,8 = 9.1, p = 0.0011; granulocytes: F 3,8 = 6.3, p = 0.0030; lymphocytes: F 3,8 = 1.2, p = 0.247, Tukey’s HSD post hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001). Paired t-tests (n = 3) were used to evaluate differences among the groups in (d). Values of p < 0.05 are considered statistically significant, and are presented as follows: # p < 0.05.
    Cd16 G7 Pig Igg1, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd16 g7 pig igg1/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    cd16 g7 pig igg1 - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    anti cd16 antibody  (Bio-Rad)
    93
    Bio-Rad anti cd16 antibody
    The surface maker for the antibody used in this study.
    Anti Cd16 Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd16 antibody/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    anti cd16 antibody - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    anti swcd16 bio rad mca1971ga g7 igg1  (Bio-Rad)
    93
    Bio-Rad anti swcd16 bio rad mca1971ga g7 igg1
    The surface maker for the antibody used in this study.
    Anti Swcd16 Bio Rad Mca1971ga G7 Igg1, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti swcd16 bio rad mca1971ga g7 igg1/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    anti swcd16 bio rad mca1971ga g7 igg1 - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Flow cytometry analysis of MCs collected before and after acute inflammation: (a) MCs’ analysis using CD14 and CD16 markers revealed the shift in surface marker intensity of a specific cell population at different stages of acute inflammation. (b) Cell-specific gating showed that primarily monocytes transited toward a CD14++/16+ state following acute inflammation. Interestingly, these cells marker intensity come to initial state after prolonged periods of acute inflammation. (c) The fraction of CD14++/16+ monocytes shows a profile similar to that of in vitro differentiated EC-like cells at different periods of acute inflammation. This implies that monocytes in CD14++/16+ state significantly contribute to the differentiation of EC-like cells in vitro . However, no significant intensity shift was observed in granulocytes or lymphocytes. In vitro treatment of PBMC with IL-6 also promotes monocyte transition toward a CD14++/16+ state and increases the EC-like cell fraction. (d) In vitro IL-6 treatment significantly enhances the population of CD34+, VEGFR2+, and CD163+ monocytes. Data were expressed as means ± standard deviations of one representative experiment out of three experiments carried out in triplicate (one-way ANOVA, Fraction ratio of monocytes: F 3,8 = 9.1, p = 0.0011; granulocytes: F 3,8 = 6.3, p = 0.0030; lymphocytes: F 3,8 = 1.2, p = 0.247, Tukey’s HSD post hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001). Paired t-tests (n = 3) were used to evaluate differences among the groups in (d). Values of p < 0.05 are considered statistically significant, and are presented as follows: # p < 0.05.

    Journal: Journal of Tissue Engineering

    Article Title: Blood mononuclear cells induce accelerated vascular remodeling under acute inflammation in vitro

    doi: 10.1177/20417314251381716

    Figure Lengend Snippet: Flow cytometry analysis of MCs collected before and after acute inflammation: (a) MCs’ analysis using CD14 and CD16 markers revealed the shift in surface marker intensity of a specific cell population at different stages of acute inflammation. (b) Cell-specific gating showed that primarily monocytes transited toward a CD14++/16+ state following acute inflammation. Interestingly, these cells marker intensity come to initial state after prolonged periods of acute inflammation. (c) The fraction of CD14++/16+ monocytes shows a profile similar to that of in vitro differentiated EC-like cells at different periods of acute inflammation. This implies that monocytes in CD14++/16+ state significantly contribute to the differentiation of EC-like cells in vitro . However, no significant intensity shift was observed in granulocytes or lymphocytes. In vitro treatment of PBMC with IL-6 also promotes monocyte transition toward a CD14++/16+ state and increases the EC-like cell fraction. (d) In vitro IL-6 treatment significantly enhances the population of CD34+, VEGFR2+, and CD163+ monocytes. Data were expressed as means ± standard deviations of one representative experiment out of three experiments carried out in triplicate (one-way ANOVA, Fraction ratio of monocytes: F 3,8 = 9.1, p = 0.0011; granulocytes: F 3,8 = 6.3, p = 0.0030; lymphocytes: F 3,8 = 1.2, p = 0.247, Tukey’s HSD post hoc test, * p < 0.05, ** p < 0.01, *** p < 0.001). Paired t-tests (n = 3) were used to evaluate differences among the groups in (d). Values of p < 0.05 are considered statistically significant, and are presented as follows: # p < 0.05.

    Article Snippet: MCs and EC-like cells were stained with FITC-conjugated CD14 (MCA1218F), PE-conjugated anti-CD31 (MCA1746PET), and PE-conjugated CD16 (MCA1971PE) supplied by Bio-Rad Laboratories (Montreal, Quebec), and CD34 (bs-0646R-PE, Bioss Antibody Inc., Boston, MA, USA).

    Techniques: Flow Cytometry, Marker, In Vitro

    The surface maker for the antibody used in this study.

    Journal: Materials Today Bio

    Article Title: Vascular tissue reconstruction by monocyte subpopulations on small-diameter acellular grafts via integrin activation

    doi: 10.1016/j.mtbio.2023.100847

    Figure Lengend Snippet: The surface maker for the antibody used in this study.

    Article Snippet: The cells were stained with PE-conjugated anti-CD31 antibody (MCA1746PET, Bio-Rad Laboratories, Montreal, Quebec), anti-CD34 antibody (bs-0646R-PE, Bioss Antibody Inc.), anti-CD105 antibody (bs-0579R-PE, Bioss Antibody Inc.), and anti-Flk-1 antibody (bs-0565R-PE, Bioss Antibody Inc), anti-CD163 antibody (bs-2527R-PE, Bioss Antibody Inc.), anti-CD14 antibody (MCA1218F, Bio-Rad Laboratories, Inc., Hercules, CA), and anti-CD16 antibody (MCA1971PE, Bio-Rad Laboratories, Inc.).

    Techniques: Expressing, Marker

    Surface marker analysis of captured cells and porcine monocyte. The captured cells were isolated from the 3 h transplantation P-graft. a , Expression levels of CD31, CD34, CD105 and Flk-1 in CC-3H were indicated. b , Two-dimensional expression patterns of CD163/CD14 and CD16/CD14 in the captured cells were plotted. c , Two-dimensional expression patterns of CD163/CD14 and CD16/CD14 in the porcine monocyte were plotted. The MoN and MoP populations were expressed CD14 Low /CD16 Low /CD163 + and CD14 + /CD16 + /CD163 + , respectively.

    Journal: Materials Today Bio

    Article Title: Vascular tissue reconstruction by monocyte subpopulations on small-diameter acellular grafts via integrin activation

    doi: 10.1016/j.mtbio.2023.100847

    Figure Lengend Snippet: Surface marker analysis of captured cells and porcine monocyte. The captured cells were isolated from the 3 h transplantation P-graft. a , Expression levels of CD31, CD34, CD105 and Flk-1 in CC-3H were indicated. b , Two-dimensional expression patterns of CD163/CD14 and CD16/CD14 in the captured cells were plotted. c , Two-dimensional expression patterns of CD163/CD14 and CD16/CD14 in the porcine monocyte were plotted. The MoN and MoP populations were expressed CD14 Low /CD16 Low /CD163 + and CD14 + /CD16 + /CD163 + , respectively.

    Article Snippet: The cells were stained with PE-conjugated anti-CD31 antibody (MCA1746PET, Bio-Rad Laboratories, Montreal, Quebec), anti-CD34 antibody (bs-0646R-PE, Bioss Antibody Inc.), anti-CD105 antibody (bs-0579R-PE, Bioss Antibody Inc.), and anti-Flk-1 antibody (bs-0565R-PE, Bioss Antibody Inc), anti-CD163 antibody (bs-2527R-PE, Bioss Antibody Inc.), anti-CD14 antibody (MCA1218F, Bio-Rad Laboratories, Inc., Hercules, CA), and anti-CD16 antibody (MCA1971PE, Bio-Rad Laboratories, Inc.).

    Techniques: Marker, Isolation, Transplantation Assay, Expressing

    Outgrowth capacity and surface marker analysis of captured cells a , Outgrowth capacity was evaluated on the cell culture plate. The cells were grown from the tissue after 3 days. b,c, Two-type cells were isolated from the single colony cultivation. The cells were classified into ( b) filopodia-shaped (CC-3D 1 ) and (c) spindle-shaped (CC-3D 2 ) cells based on the difference in morphology. These cells were expressed the surface maker of CD16/CD14. d , e , Surface marker expression of CD31, CD34, CD105, and Flk-1 on ( d ) CC-3D 1 and ( e ) CC-3D 2 were indicated. f , Di-ac-LDL uptake of the mixture of CC-3D 1 and CC-3D 2 was compared to the fibroblast and endothelial cells on CLSM observation.

    Journal: Materials Today Bio

    Article Title: Vascular tissue reconstruction by monocyte subpopulations on small-diameter acellular grafts via integrin activation

    doi: 10.1016/j.mtbio.2023.100847

    Figure Lengend Snippet: Outgrowth capacity and surface marker analysis of captured cells a , Outgrowth capacity was evaluated on the cell culture plate. The cells were grown from the tissue after 3 days. b,c, Two-type cells were isolated from the single colony cultivation. The cells were classified into ( b) filopodia-shaped (CC-3D 1 ) and (c) spindle-shaped (CC-3D 2 ) cells based on the difference in morphology. These cells were expressed the surface maker of CD16/CD14. d , e , Surface marker expression of CD31, CD34, CD105, and Flk-1 on ( d ) CC-3D 1 and ( e ) CC-3D 2 were indicated. f , Di-ac-LDL uptake of the mixture of CC-3D 1 and CC-3D 2 was compared to the fibroblast and endothelial cells on CLSM observation.

    Article Snippet: The cells were stained with PE-conjugated anti-CD31 antibody (MCA1746PET, Bio-Rad Laboratories, Montreal, Quebec), anti-CD34 antibody (bs-0646R-PE, Bioss Antibody Inc.), anti-CD105 antibody (bs-0579R-PE, Bioss Antibody Inc.), and anti-Flk-1 antibody (bs-0565R-PE, Bioss Antibody Inc), anti-CD163 antibody (bs-2527R-PE, Bioss Antibody Inc.), anti-CD14 antibody (MCA1218F, Bio-Rad Laboratories, Inc., Hercules, CA), and anti-CD16 antibody (MCA1971PE, Bio-Rad Laboratories, Inc.).

    Techniques: Marker, Cell Culture, Isolation, Expressing

    In vitro differentiation assay on decellularized graft a , Schematic image of the culture plate with decellularized tissue and REDV-modified decellularized tissue. b , Two-dimensional plot showing the SSC and FSC signals of pre-seeding cells and cultured cells on the REDV-modified surface for 7 and 14 days. c, d , Surface marker analysis by FACS; the surface maker expressions of CD14 and CD16 are indicated. The blue line indicates the expression of the monocyte fraction. The black and red lines indicate the expression levels of the cells captured on the Un-graft and P-graft surfaces, respectively. d , Surface marker expression of CD31 and CD34 were indicated. In both cases, monocytes and cultured cells on decellularized and REDV-tissue surface for 7 and 14 days were evaluated. The gray-filled distribution indicates the unstained cells. The blue line indicates the antibody-stained monocyte. Black and red lines indicate the antibody-stained cells cultured on the unmodified and REDV-modified decellularized surfaces, respectively. e , Fraction rate of CD31 and CD34 in the cultured cells on unmodified and REDV-modified surfaces plotted against cultivation time. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: Vascular tissue reconstruction by monocyte subpopulations on small-diameter acellular grafts via integrin activation

    doi: 10.1016/j.mtbio.2023.100847

    Figure Lengend Snippet: In vitro differentiation assay on decellularized graft a , Schematic image of the culture plate with decellularized tissue and REDV-modified decellularized tissue. b , Two-dimensional plot showing the SSC and FSC signals of pre-seeding cells and cultured cells on the REDV-modified surface for 7 and 14 days. c, d , Surface marker analysis by FACS; the surface maker expressions of CD14 and CD16 are indicated. The blue line indicates the expression of the monocyte fraction. The black and red lines indicate the expression levels of the cells captured on the Un-graft and P-graft surfaces, respectively. d , Surface marker expression of CD31 and CD34 were indicated. In both cases, monocytes and cultured cells on decellularized and REDV-tissue surface for 7 and 14 days were evaluated. The gray-filled distribution indicates the unstained cells. The blue line indicates the antibody-stained monocyte. Black and red lines indicate the antibody-stained cells cultured on the unmodified and REDV-modified decellularized surfaces, respectively. e , Fraction rate of CD31 and CD34 in the cultured cells on unmodified and REDV-modified surfaces plotted against cultivation time. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: The cells were stained with PE-conjugated anti-CD31 antibody (MCA1746PET, Bio-Rad Laboratories, Montreal, Quebec), anti-CD34 antibody (bs-0646R-PE, Bioss Antibody Inc.), anti-CD105 antibody (bs-0579R-PE, Bioss Antibody Inc.), and anti-Flk-1 antibody (bs-0565R-PE, Bioss Antibody Inc), anti-CD163 antibody (bs-2527R-PE, Bioss Antibody Inc.), anti-CD14 antibody (MCA1218F, Bio-Rad Laboratories, Inc., Hercules, CA), and anti-CD16 antibody (MCA1971PE, Bio-Rad Laboratories, Inc.).

    Techniques: In Vitro, Differentiation Assay, Modification, Cell Culture, Marker, Expressing, Staining